1,2,3-Propanetricarboxylic acid, 2-hydroxy-, tri-C12-13-branched alkyl esters

Repeated dose toxicity: dermal

Administrative data

Endpoint:

sub-chronic toxicity: dermal

Data waiving:

study scientifically not necessary / other information available

Justification for data waiving:

other:

Results and discussion

Target system / organ toxicity

Critical effects observed:

not specified

Applicant's summary and conclusion

Executive summary:

In the 28 - days repeated dose study via oral gavage administration only minor effects at higher doses have been observed.This intrinsic property/toxicity potential can be extrapolated to repeated dermal route administration.